Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10777181 | 0.92 | TSHR (0.56) | ALDH1A1TSHRHCAR2NAAARAD52 | |
| SCHEMBL21202163 | 0.92 | TSHR (0.56) | ALDH1A1TSHRHCAR2NAAARAD52 | |
| SCHEMBL2992405 | 0.87 | HCAR2 (0.38) | ALDH1A1TSHRHCAR2TDP1ESR1 | |
| SCHEMBL5501929 | 0.84 | ALDH1A1 (0.67) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL28787473 | 0.84 | ALDH1A1 (0.67) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL137155 | 0.84 | ALDH1A1 (0.67) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL9305347 | 0.83 | TSHR (0.66) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL28131973 | 0.82 | ALDH1A1 (0.64) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| Fluoride SCHEMBL3958324 | 0.82 | ALDH1A1 (0.64) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL5501926 | 0.82 | ALDH1A1 (0.64) | ALDH1A1ATMTSHRHPGDHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016126-A1 | METHOD FOR MANUFACTURING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE | DONG-A PHARMACEUTICAL. CO., LTD (KR) | 2012-01-19 | — | — | US | claimed |
| EP-1989220-B1 | HIV FUSION INHIBITOR PEPTIDES WITH IMPROVED BIOLOGICAL PROPERTIES | TRIMERIS INC (US) | 2011-12-14 | — | — | EP | claimed |
| EP-0538692-A1 | Use of partly known substituted pyrrolidine derivatives as pharmaceuticals, new compounds and process for their preparation | BAYER AG (DE) | 1993-04-28 | — | — | EP | claimed |
| EP-3259255-A1 | (2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYLOXAZOLE-2-CARBONYL)AMINO]PENTANOIC ACID | Theravance Biopharma R&D IP, LLC (US) | 2017-12-27 | — | — | EP | disclosed |
| EP-3256446-A1 | (2S, 4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-ETHOXYOXALYLAMINO)-2-HYDROXYMETHYL-2-METHYLPENTANOIC ACID AS NEPRILYSIN INHIBITOR | Theravance Biopharma R&D IP, LLC (US) | 2017-12-20 | — | — | EP | disclosed |
| EP-1373185-B1 | HYDROPHOBIC POLYAMINE ANALOGS AND METHODS FOR THEIR USE | AMINEX THERAPEUTICS INC (US) | 2017-03-01 | — | — | EP | disclosed |
| WO-2016133803-A1 | (2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYLOXAZOLE-2-CARBONYL)AMINO]PENTANOIC ACID | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2016-08-25 | — | — | WO | disclosed |
| WO-2016130650-A1 | (2S, 4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-ETHOXYOXALYLAMINO)-2-HYDROXYMETHYL-2-METHYLPENTANOIC ACID AS NEPRILYSIN INHIBITOR | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2016-08-18 | — | — | WO | disclosed |
| US-9066954-B2 | Fused heterocyclic derivatives and methods of use | AMGEN INC. (US) | 2015-06-30 | — | — | US | disclosed |
| US-8865935-B2 | Purification methods for betulonic acid and Boc-lysinated betulonic acid, and organic synthesis of betulonic acid amides with piperazine derivatives | KOREA INSTITUTE OF ENERGY RESEARCH (KR) | 2014-10-21 | — | — | US | disclosed |
| US-20140243527-A1 | PURIFICATION METHODS FOR BETULONIC ACID AND BOC-LYSINATED BETULONIC ACID, AND ORGANIC SYNTHESIS OF BETULONIC ACID AMIDES WITH PIPERAZINE DERIVATIVES | KOREA INSTITUTE OF ENERGY RESEARCH (KR) | 2014-08-28 | — | — | US | disclosed |
| US-5885979-A | SQUALENE SYNTHETASE INHIBITOR TREATING OR PREVENTING HYPERLIPIDEMIA | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-23 | — | — | US | disclosed |
| US-5843693-A | Assay method for screening for inhibitors of proTNF conversion | CHIRON CORPORATION (US) | 1998-12-01 | — | — | US | disclosed |
| US-5726306-A | INHIBITORS OF SQUALENE SYNTHETASE AND FUNGAL GROWTH; USEFUL IN TREATING AND PREVENTING HYPERLIPIDEMIA | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-10 | — | — | US | disclosed |
| WO-1997002286-A1 | NOVEL ANTIBIOTIC PEPTIDES | MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) | 1997-01-23 | — | — | WO | disclosed |
| EP-0567026-A1 | 4,1-Benzoxazepin derivatives as squalene synthase inhibitors and their use in the treatment of hypercholesteremia and as fungicides | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-10-27 | — | — | EP | disclosed |
| EP-0464430-A1 | 2-Aminoalkyl-pyrrolealdehyde, process of preparation and use | CASSELLA Aktiengesellschaft (DE) | 1992-01-08 | — | — | EP | disclosed |
| US-4735651-A | HERBICIDES; ROOT INHIBITION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1988-04-05 | — | — | US | disclosed |
| WO-1988000950-A2 | PRODUCTION OF COVALENT-LINKED CONJUGATES FROM AN ANTIBIOTIC AND A NON-TOXIC DERIVATIVE OF POLYMYXINE B | FAUCHERE JEAN LUC (CH) | 1988-02-11 | — | — | WO | disclosed |
| EP-0192135-A2 | Oligopeptidylargininol derivatives and their homologues, process for their preparation, their use and agents containing them | BEHRINGWERKE Aktiengesellschaft (DE) | 1986-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016126-A1 | METHOD FOR MANUFACTURING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE | DPP4, DPP3, DPP7 | ALDH1A1 752/4885ATM 4671/4885TSHR 2902/4885 |
| US-20140243527-A1 | PURIFICATION METHODS FOR BETULONIC ACID AND BOC-LYSINATED BETULONIC ACID, AND ORGANIC SYNTHESIS OF BETULONIC ACID AMIDES WITH PIPERAZINE DERIVATIVES | BET1, LOX, BECN1 | ALDH1A1 3355/4885ATM 4028/4885TSHR 3657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.